Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication
Clinical trial NCT05014334 · COMPLETED
Trial details
- NCT number
- NCT05014334
- Sponsor
- Xijing Hospital of Digestive Diseases
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-03-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.